More,
almost live blogging, from the NAD conference. During the
mid-morning hours yesterday, the conference group focused on
strategies to get their claim substantiation right. The panel
of Kat Dunnigan (NAD); Rebecca Bliebaum (Tragon Corporation); Jay
Goldring (Boots Retail USA, Inc); Spring C. Potoczak (Novartis
Consumer Health, Inc.); and moderated by David Mallen (Loeb &
Loeb, LLP) focused on the sufficiency of different types of claim
substantiation.
The panel started the conversation by discussing how much
substantiation is needed for a given claim. In other words,
what constitutes competent and reliable scientific evidence.
The panel said that randomized controlled trials (RCT) are
generally thought of as the gold standard of support for
advertising claims. However, the panel noted that RCTs are
not required in all cases. In fact, David Mallen noted that
the DC Circuit has said that RCTs are not necessarily the standard
for advertising claim support.